Soleno Therapeutics, Inc.
SLNO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$176 | -$39 | -$24 | -$31 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $100 | $6 | $3 | $3 |
| Change in WC | $6 | $3 | -$1 | -$1 |
| Other Non-Cash | -$1 | $3 | -$0 | -$1 |
| Operating Cash Flow | -$69 | -$25 | -$21 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$356 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $131 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$226 | $0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $50 | $0 | $0 | -$0 |
| Stock Issued | $149 | $138 | $14 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14 | $42 | -$0 | -$0 |
| Financing Cash Flow | $213 | $180 | $14 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$82 | $155 | -$7 | -$28 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $170 | $15 | $21 | $49 |
| End Cash | $88 | $170 | $15 | $21 |
| Free Cash Flow | -$69 | -$25 | -$21 | -$28 |